SciClone Pharmaceuticals (Holdings) Limited

SEHK:6600 Stock Report

Mkt Cap: HK$6.8b

SciClone Pharmaceuticals (Holdings) Management

How experienced are the management team and are they aligned to shareholders interests?

1.9yrs

Average management tenure


CEO

Hong Zhao (59 yo)

2.58yrs

Tenure

CN¥25,840,000

Compensation

Mr. Hong Zhao has been President and Chief Executive Officer at SciClone Pharmaceuticals (Holdings) Limited since June 24, 2020 and also serves as its Executive Director since June 24, 2020. Mr. Zhao serve...


CEO Compensation Analysis

How has Hong Zhao's remuneration changed compared to SciClone Pharmaceuticals (Holdings)'s earnings?
DateTotal Comp.SalaryCompany Earnings
Jun 30 2022n/an/a

CN¥833m

Mar 31 2022n/an/a

CN¥878m

Dec 31 2021CN¥26mCN¥7m

CN¥923m

Sep 30 2021n/an/a

CN¥837m

Jun 30 2021n/an/a

CN¥779m

Mar 31 2021n/an/a

CN¥766m

Dec 31 2020CN¥29mCN¥7m

CN¥754m

Sep 30 2020n/an/a

CN¥817m

Dec 31 2019CN¥15mCN¥6m

CN¥615m

Dec 31 2018n/an/a

CN¥535m

Dec 31 2017n/an/a

CN¥20m

Jun 30 2017n/an/a

CN¥294m

Mar 31 2017n/an/a

CN¥258m

Dec 31 2016CN¥12mCN¥3m

CN¥213m

Compensation vs Market: Hong's total compensation ($USD3.81M) is above average for companies of similar size in the Hong Kong market ($USD555.77K).

Compensation vs Earnings: Hong's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Hong Zhao
CEO, President & Executive Director2.58yrsCN¥25.84m0.029%
CN¥ 2.0m
Rongrong Pan
Joint Company Secretary1.92yrsno datano data
Chihwen Shao
VP & Head of Technical Operations and Pharmacovigilance1yrno datano data
Min Jia
VP & Head of Immunization Business Unitno datano datano data
Yansong Chang
VP & GM of Oncology Business Unitno datano datano data
Mingxiang Wu
VP and Head of Market Access & Commercial Operation (MACO) Departmentno datano datano data
Xiaoning Guo
VP, Head of Research & Development Department and Chief Medical Officerno datano datano data
Lianzong Wu
VP and Head of Registration & Pharmaceutical Affairs Departmentno datano datano data
Li Mao
VP, GM of Research and Development & Chief Medical Officer0.58yrno datano data
Sin Man Chan
Joint Company Secretary1.92yrsno datano data

1.9yrs

Average Tenure

52yo

Average Age

Experienced Management: 6600's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Hong Zhao
CEO, President & Executive Director2.58yrsCN¥25.84m0.029%
CN¥ 2.0m
Guoen Liu
Independent Non-Executive Director1.92yrsCN¥569.00kno data
Zhenfu Li
Non-Executive Chairman2.58yrsno datano data
Cen Shi
Non-Executive Director2.58yrsno datano data
Wendy Hayes
Independent Non-Executive Director1.92yrsCN¥569.00kno data
Haixia Wang
Non-Executive Director1.58yrsno datano data
Daniel Luzius Vasella
Non-Executive Director2.42yrsCN¥569.00kno data
Yi-Hsien Lin
Non-Executive Director1.92yrsno datano data
Ping Chen
Independent Non-Executive Director1.92yrsCN¥569.00kno data
Yushao Gu
Independent Non-Executive Director1.92yrsCN¥569.00kno data
Wang Zhang
Independent Non-Executive Directorno datano datano data

1.9yrs

Average Tenure

55.5yo

Average Age

Experienced Board: 6600's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.